Clinical Trial Update: A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weight change after 24 weeks of LIK066 treatment in overweight or obese adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LIK066 (LIK066)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED | Results posted: 2020-02-06